FORT WORTH, Texas, Sept. 20, 2016 (GLOBE NEWSWIRE) -- American Airlines this year will begin a multi-year financial commitment of $1 million to the Answer ALS research project through the Answer ALS Foundation. The research project will build the most comprehensive clinical, genetic, molecular and biochemical assessment of ALS.
ALS, or amyotrophic lateral sclerosis, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. It is also commonly referred to as Lou Gehrig?s disease, after the famous baseball player who was diagnosed with it.
?With more than 100,000 employees at American, statistically several of our team members or their family members will receive an ALS diagnosis. Most recently, Vice President, Finance Peter Warlick disclosed his personal battle with ALS. Since receiving his diagnosis, Peter has become a champion for all American employees fighting this disease by exploring the current state of research available to those afflicted with ALS, and determining more can be done,? said Doug Parker, CEO of American Airlines. ?We are proud to partner with Peter and Answer ALS on behalf of all American employees who are suffering from ALS. Similar to American?s support of the Cystic Fibrosis Foundation, we believe there is a real opportunity to bring attention to orphan diseases like ALS that require additional awareness and fundraising support in order to bring them to an end.?